THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTION

Aim: to determine the association between plasma concentrations of biomarkers (sCD40L, PDGF-BB, PlGF-1, ST2) with histochemical and immunohistochemical signs of heart rejection.Materials and methods. The study included 98 heart recipients aged from 12 to 69 (mean age 43 ± 14) years, of which 78 men....

Full description

Bibliographic Details
Main Authors: O. P. Shevchenko, A. A. Ulybysheva, A. V. Aksyonova, N. P. Mozhejko, E. A. Stakhanova, V. V. Dontsov, E. A. Nikitina, A. O. Shevchenko
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2017-01-01
Series:Vestnik Transplantologii i Iskusstvennyh Organov
Subjects:
Online Access:https://journal.transpl.ru/vtio/article/view/702
_version_ 1797872007174422528
author O. P. Shevchenko
A. A. Ulybysheva
A. V. Aksyonova
N. P. Mozhejko
E. A. Stakhanova
V. V. Dontsov
E. A. Nikitina
A. O. Shevchenko
author_facet O. P. Shevchenko
A. A. Ulybysheva
A. V. Aksyonova
N. P. Mozhejko
E. A. Stakhanova
V. V. Dontsov
E. A. Nikitina
A. O. Shevchenko
author_sort O. P. Shevchenko
collection DOAJ
description Aim: to determine the association between plasma concentrations of biomarkers (sCD40L, PDGF-BB, PlGF-1, ST2) with histochemical and immunohistochemical signs of heart rejection.Materials and methods. The study included 98 heart recipients aged from 12 to 69 (mean age 43 ± 14) years, of which 78 men. In 68 patients dilated cardiomyopathy was diagnosed, 30 recipients were diagnosed with coronary heart disease. The concentrations of placental growth factor (PlGF-1), platelet-derived growth factor (PDGF-BB), soluble CD40 ligand (sCD40L) were measured using xMAP technology. The concentrations of ST2 cardiac biomarker were measured by ELISA.Results. No correlation was found between the levels of biomarkers (sCD40L, PDGF-BB, PlGF-1, ST2) and gender, age and diagnosis. The rejection was diagnosed via biopsy in 49 biopsies taken from 37 recipients. 1A rejection was found in 25 patients (34 biopsies), 1B rejection was identifi ed in 2 patients (3 biopsies), 3A rejection was diagnosed in 4 patients. Immunohistochemical signs of humoral rejection were identifi ed in 3 patients. The combination of acute cellular and humoral rejection was found in 4 patients (5 biopsies). The PDGFBB level was measured at the same day as the biopsy was taken, and it was shown to be signifi cantly higher in patients with rejection (p = 0.02). Rejection frequency was signifi cantly higher in patients with high PDGF-BB level (≥2473.7 pg/ml, RR = 1.64 ± 0.23; 95% CI [1.03–2.61]). Rejection frequency increased to 2.11 ± 0.34 [95% CI [1.08–4.11]] in recipients with ST2 and PDGF-BB concentration higher than the median value. The highest predictive value for heart rejection can be reached by a panel of three biomarkers: sCD40L, PlGF-1 and ST2 (RR = 2.51 ± 0.38; 95% CI [1.18–5.3]).Conclusion. PDGF-BB has moderate predictive value for heart rejection. The highest predictive value for heart rejection was reached by a panel of three biomarkers: sCD40L, PlGF-1 and ST2.
first_indexed 2024-04-10T00:53:05Z
format Article
id doaj.art-7f00f4ead1bc4429b46a060583fd6a51
institution Directory Open Access Journal
issn 1995-1191
language Russian
last_indexed 2024-04-10T00:53:05Z
publishDate 2017-01-01
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
record_format Article
series Vestnik Transplantologii i Iskusstvennyh Organov
spelling doaj.art-7f00f4ead1bc4429b46a060583fd6a512023-03-13T10:37:23ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovVestnik Transplantologii i Iskusstvennyh Organov1995-11912017-01-01184717610.15825/1995-1191-2016-4-71-76586THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTIONO. P. Shevchenko0A. A. Ulybysheva1A. V. Aksyonova2N. P. Mozhejko3E. A. Stakhanova4V. V. Dontsov5E. A. Nikitina6A. O. Shevchenko7V.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation I.M. Sechenov First Moscow State Medical UniversityV.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation N.I. Pirogov Russian National Research Medical UniversityV.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian FederationI.M. Sechenov First Moscow State Medical UniversityV.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian FederationV.I. Shumakov Federal Research Center of Transplantology and Artifi cial Organs of the Ministry of Healthcare of the Russian Federation I.M. Sechenov First Moscow State Medical UniversityAim: to determine the association between plasma concentrations of biomarkers (sCD40L, PDGF-BB, PlGF-1, ST2) with histochemical and immunohistochemical signs of heart rejection.Materials and methods. The study included 98 heart recipients aged from 12 to 69 (mean age 43 ± 14) years, of which 78 men. In 68 patients dilated cardiomyopathy was diagnosed, 30 recipients were diagnosed with coronary heart disease. The concentrations of placental growth factor (PlGF-1), platelet-derived growth factor (PDGF-BB), soluble CD40 ligand (sCD40L) were measured using xMAP technology. The concentrations of ST2 cardiac biomarker were measured by ELISA.Results. No correlation was found between the levels of biomarkers (sCD40L, PDGF-BB, PlGF-1, ST2) and gender, age and diagnosis. The rejection was diagnosed via biopsy in 49 biopsies taken from 37 recipients. 1A rejection was found in 25 patients (34 biopsies), 1B rejection was identifi ed in 2 patients (3 biopsies), 3A rejection was diagnosed in 4 patients. Immunohistochemical signs of humoral rejection were identifi ed in 3 patients. The combination of acute cellular and humoral rejection was found in 4 patients (5 biopsies). The PDGFBB level was measured at the same day as the biopsy was taken, and it was shown to be signifi cantly higher in patients with rejection (p = 0.02). Rejection frequency was signifi cantly higher in patients with high PDGF-BB level (≥2473.7 pg/ml, RR = 1.64 ± 0.23; 95% CI [1.03–2.61]). Rejection frequency increased to 2.11 ± 0.34 [95% CI [1.08–4.11]] in recipients with ST2 and PDGF-BB concentration higher than the median value. The highest predictive value for heart rejection can be reached by a panel of three biomarkers: sCD40L, PlGF-1 and ST2 (RR = 2.51 ± 0.38; 95% CI [1.18–5.3]).Conclusion. PDGF-BB has moderate predictive value for heart rejection. The highest predictive value for heart rejection was reached by a panel of three biomarkers: sCD40L, PlGF-1 and ST2.https://journal.transpl.ru/vtio/article/view/702heart transplantationrejectionbiomarkersmultiplex analysisscd40lpdgf-bbplgf-1st2.
spellingShingle O. P. Shevchenko
A. A. Ulybysheva
A. V. Aksyonova
N. P. Mozhejko
E. A. Stakhanova
V. V. Dontsov
E. A. Nikitina
A. O. Shevchenko
THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTION
Vestnik Transplantologii i Iskusstvennyh Organov
heart transplantation
rejection
biomarkers
multiplex analysis
scd40l
pdgf-bb
plgf-1
st2.
title THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTION
title_full THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTION
title_fullStr THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTION
title_full_unstemmed THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTION
title_short THE DIAGNOSTIC VALUE OF PLATELET-DERIVED FACTOR PDGF-BB AND ST2 IN HEART REJECTION
title_sort diagnostic value of platelet derived factor pdgf bb and st2 in heart rejection
topic heart transplantation
rejection
biomarkers
multiplex analysis
scd40l
pdgf-bb
plgf-1
st2.
url https://journal.transpl.ru/vtio/article/view/702
work_keys_str_mv AT opshevchenko thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT aaulybysheva thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT avaksyonova thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT npmozhejko thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT eastakhanova thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT vvdontsov thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT eanikitina thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT aoshevchenko thediagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT opshevchenko diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT aaulybysheva diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT avaksyonova diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT npmozhejko diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT eastakhanova diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT vvdontsov diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT eanikitina diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection
AT aoshevchenko diagnosticvalueofplateletderivedfactorpdgfbbandst2inheartrejection